Медицинский совет (Nov 2017)

COMBINATION THERAPY OF EROSIVE FORM OF GERD IN PATIENTS WITH THE MIXED CHARACTER OF RELUCTATE

  • D. V. Danilov,
  • A. G. Shuleshova,
  • I. V. Zverkov,
  • K. A. Bondareva

DOI
https://doi.org/10.21518/2079-701X-2017-15-23-26
Journal volume & issue
Vol. 0, no. 15
pp. 23 – 26

Abstract

Read online

The article presents the result of study of the effectiveness of a new drug dexlansoprazole in combination with the drug ursodeoxycholic acid in the group of patients with erosive esophagitis, with mixed reflux, as defined by results of 24-hour pHimpedance metering. Dynamics of clinical symptoms and endoscopic pattern when taking different doses of UDCA of primary and supportive therapy is monitored.

Keywords